Creatine supplementation for older adults: Focus on sarcopenia, osteoporosis, frailty and Cachexia

Imagem de Miniatura
Arquivos
art_CANDOW_Creatine_supplementation_for_older_adults_Focus_on_sarcopenia_2022.PDF (546.08 KB)
Citações na Scopus
14
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
CANDOW, Darren G.
CHILIBECK, Philip D.
FORBES, Scott C.
FAIRMAN, Ciaran M.
Citação
BONE, v.162, article ID 116467, 10p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Sarcopenia refers to the age-related reduction in strength, muscle mass and functionality which increases the risk for falls, injuries and fractures. Sarcopenia is associated with other age-related conditions such as osteoporosis, frailty and cachexia. Identifying treatments to overcome sarcopenia and associated conditions is important from a global health perspective. There is evidence that creatine monohydrate supplementation, primarily when combined with resistance training, has favorable effects on indices of aging muscle and bone. These musculoskeletal benefits provide some rationale for creatine being a potential intervention for treating frailty and cachexia. The purposes of this narrative review are to update the collective body of research pertaining to the effects of creatine supplementation on indices of aging muscle and bone (including bone turnover markers) and present possible justification and rationale for its utilization in the treatment of frailty and cachexia in older adults.
Palavras-chave
Muscle, Strength, Bone, Falls, Disease
URI
https://observatorio.fm.usp.br/handle/OPI/49075
Referências
  1. Aguiar AF, 2013, EUR J APPL PHYSIOL, V113, P987, DOI 10.1007/s00421-012-2514-6
  2. Antolic A, 2007, MED SCI SPORT EXER, V39, P816, DOI 10.1249/mss.0b013e318031fac4
  3. Antunes JMM, 2018, TRENDS MOL MED, V24, P709, DOI 10.1016/j.molmed.2018.06.002
  4. Aoyagi T, 2015, WORLD J GASTRO ONCOL, V7, P17, DOI 10.4251/wjgo.v7.i4.17
  5. Aversa Z, 2017, THER ADV MED ONCOL, V9, P369, DOI 10.1177/1758834017698643
  6. Avgerinos KI, 2018, EXP GERONTOL, V108, P166, DOI 10.1016/j.exger.2018.04.013
  7. Baker TP, 2016, J STRENGTH COND RES, V30, P1763, DOI 10.1519/JSC.0000000000001254
  8. Baracos VE, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2017.105
  9. Bemben MG, 2010, J NUTR HEALTH AGING, V14, P155, DOI 10.1007/s12603-009-0124-8
  10. Bender A, 2008, NUTR RES, V28, P172, DOI 10.1016/j.nutres.2008.01.001
  11. Bermon S, 1998, ACTA PHYSIOL SCAND, V164, P147, DOI 10.1046/j.1365-201X.1998.00427.x
  12. Okayama Akira, 2022, Healthcare (Basel), V10, DOI 10.3390/healthcare10020192
  13. Patel D., 2019, EFFECTS CREATINE SUP
  14. Pinkoski C, 2006, MED SCI SPORT EXER, V38, P339, DOI 10.1249/01.mss.0000183860.42853.15
  15. Pinto CL, 2016, J CACHEXIA SARCOPENI, V7, P413, DOI 10.1002/jcsm.12094
  16. Pires L.A.M., 2020, J SOC NEUROSPORTS, V1
  17. Rawson ES, 1999, EUR J APPL PHYSIOL O, V80, P139, DOI 10.1007/s004210050570
  18. Riesberg LA, 2016, INT IMMUNOPHARMACOL, V37, P31, DOI 10.1016/j.intimp.2015.12.034
  19. Alves CRR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076301
  20. Alves CRR, 2012, REV BRAS REUMATOL, V52, P453
  21. Rohrmann S, 2020, ADV EXP MED BIOL, V1216, P21, DOI 10.1007/978-3-030-33330-0_3
  22. Sales LP, 2020, J GERONTOL A-BIOL, V75, P931, DOI 10.1093/gerona/glz162
  23. Roschel H, 2021, CLIN NUTR, V40, P4849, DOI 10.1016/j.clnu.2021.06.024
  24. RUBIN CT, 1985, CALCIFIED TISSUE INT, V37, P411, DOI 10.1007/BF02553711
  25. Shetty Sahana, 2016, Indian J Endocrinol Metab, V20, P846
  26. Smolarek A.C., 2020, J EXERC PHYSL, V23
  27. SOMJEN D, 1994, J ENDOCRINOL, V143, P251, DOI 10.1677/joe.0.1430251
  28. Stout JR, 2007, J NUTR HEALTH AGING, V11, P459
  29. Tarnopolsky MA, 2004, NEUROLOGY, V62, P1771, DOI 10.1212/01.WNL.0000125178.18862.9D
  30. Tarnopolsky M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000991
  31. United Nations . Department of Economic and Social Affairs. Population Division, 2020, WORLD POP AG 2020 HI
  32. Vaughan VC, 2013, J CACHEXIA SARCOPENI, V4, P95, DOI 10.1007/s13539-012-0087-1
  33. Villanueva MG, 2014, EUR J APPL PHYSIOL, V114, P891, DOI 10.1007/s00421-014-2821-1
  34. Bernat P, 2019, APPL PHYSIOL NUTR ME, V44, P1246, DOI 10.1139/apnm-2019-0066
  35. WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955
  36. Yasuda H, 1998, ENDOCRINOLOGY, V139, P1329, DOI 10.1210/en.139.3.1329
  37. Blum D, 2014, ANN ONCOL, V25, P1635, DOI 10.1093/annonc/mdu086
  38. Bosaeus I, 2008, SUPPORT CARE CANCER, V16, P447, DOI 10.1007/s00520-007-0388-7
  39. Bourgeois JM, 2008, PEDIATR BLOOD CANCER, V51, P183, DOI 10.1002/pbc.21571
  40. Brose A, 2003, J GERONTOL A-BIOL, V58, P11
  41. Candow DG, 2008, MED SCI SPORT EXER, V40, P1645, DOI 10.1249/MSS.0b013e318176b310
  42. Candow DG, 2021, MED SCI SPORT EXER, V53, P2388, DOI 10.1249/MSS.0000000000002722
  43. Candow DG, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030745
  44. Candow Darren G., 2021, Nutrition and Health (Bicester), V27, p0260106020975247, DOI 10.1177/0260106020975247
  45. Candow DG, 2019, J CLIN MED, V8, DOI 10.3390/jcm8040488
  46. Candow DG, 2019, EXP GERONTOL, V119, P89, DOI 10.1016/j.exger.2019.01.025
  47. Candow DG, 2015, APPL PHYSIOL NUTR ME, V40, P689, DOI 10.1139/apnm-2014-0498
  48. Candow DG, 2014, ENDOCRINE, V45, P354, DOI 10.1007/s12020-013-0070-4
  49. Canete S, 2006, J STRENGTH COND RES, V20, P22
  50. Chami J, 2019, J NUTR HEALTH AGING, V23, P281, DOI 10.1007/s12603-018-1148-8
  51. Chilibeck PD, 2005, J NUTR HEALTH AGING, V9, P352
  52. Chilibeck PD, 2017, OPEN ACCESS J SPORTS, V8, P213, DOI 10.2147/OAJSM.S123529
  53. Chilibeck PD, 2015, MED SCI SPORT EXER, V47, P1587, DOI 10.1249/MSS.0000000000000571
  54. CHNG JLC, 1994, J BIOL CHEM, V269, P2336
  55. Chrusch MJ, 2001, MED SCI SPORT EXER, V33, P2111, DOI 10.1097/00005768-200112000-00021
  56. Churchward-Venne TA, 2012, J PHYSIOL-LONDON, V590, P2751, DOI 10.1113/jphysiol.2012.228833
  57. Coletta A., 2019, RESISTANCE TRAINING
  58. Coll PP, 2021, J AM GERIATR SOC, V69, P1388, DOI 10.1111/jgs.17043
  59. Collins J., 2016, J FRALITY AGING, V5, P126, DOI [10.14283/JFA.2016.85, DOI 10.14283/jfa.2016.85]
  60. Cooke MB, 2014, EUR J APPL PHYSIOL, V114, P1321, DOI 10.1007/s00421-014-2866-1
  61. Cornish SM, 2009, INT J SPORT NUTR EXE, V19, P79, DOI 10.1123/ijsnem.19.1.79
  62. Crockett K, 2018, J AGING PHYS ACTIV, V26, P136, DOI 10.1123/japa.2016-0132
  63. Cruz-Jentoft AJ, 2019, LANCET, V393, P2636, DOI 10.1016/S0140-6736(19)31138-9
  64. de Souza RA, 2012, LASER MED SCI, V27, P487, DOI 10.1007/s10103-011-0976-0
  65. Deacon SJ, 2008, AM J RESP CRIT CARE, V178, P233, DOI 10.1164/rccm.200710-1508OC
  66. Dent E, 2018, J NUTR HEALTH AGING, V22, P1148, DOI 10.1007/s12603-018-1139-9
  67. Devries MC, 2014, MED SCI SPORT EXER, V46, P1194, DOI 10.1249/MSS.0000000000000220
  68. dos Santos EEP, 2021, NUTRIENTS, V13, DOI 10.3390/nu13113757
  69. Dunne RF, 2017, CURR OPIN SUPPORT PA, V11, P278, DOI 10.1097/SPC.0000000000000301
  70. Eijnde BO, 2003, J APPL PHYSIOL, V95, P818, DOI 10.1152/japplphysiol.00891.2002
  71. Eliot KA, 2008, J NUTR HEALTH AGING, V12, P208, DOI 10.1007/BF02982622
  72. Fairman C.M, 2019, BMJ OPEN, V9, DOI [10.1136/BMJOPEN-2019, DOI 10.1136/BMJOPEN-2019]
  73. Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7
  74. Forbes SC, 2022, NUTRIENTS, V14, DOI 10.3390/nu14050921
  75. Forbes SC, 2022, ANN NUTR METAB, V78, P183, DOI 10.1159/000520967
  76. Forbes SC, 2021, NUTRIENTS, V13, DOI 10.3390/nu13061912
  77. Forbes SC, 2022, J DIET SUPPL, V19, P318, DOI 10.1080/19390211.2021.1877232
  78. Forbes SC, 2018, FRONT NUTR, V5, DOI 10.3389/fnut.2018.00027
  79. Fragala MS, 2019, J STRENGTH COND RES, V33, P2019, DOI 10.1519/JSC.0000000000003230
  80. Frank-Wilson AW, 2016, OSTEOPOROSIS INT, V27, P2231, DOI 10.1007/s00198-016-3514-x
  81. Gerber I, 2005, Eur Cell Mater, V10, P8
  82. Gotshalk LA, 2002, MED SCI SPORT EXER, V34, P537, DOI 10.1097/00005768-200203000-00023
  83. Gotshalk LA, 2008, EUR J APPL PHYSIOL, V102, P223, DOI 10.1007/s00421-007-0580-y
  84. Gualano B, 2016, AMINO ACIDS, V48, P1793, DOI 10.1007/s00726-016-2239-7
  85. Gualano B, 2014, EXP GERONTOL, V53, P7, DOI 10.1016/j.exger.2014.02.003
  86. Gualano B, 2011, MED SCI SPORT EXER, V43, P770, DOI 10.1249/MSS.0b013e3181fcee7d
  87. Guralnik J, 2020, J FRALITY AGING, V9, P9, DOI 10.14283/jfa.2019.33
  88. HARRIS RC, 1992, CLIN SCI, V83, P367, DOI 10.1042/cs0830367
  89. Hass CJ, 2007, NEUROREHAB NEURAL RE, V21, P107, DOI 10.1177/1545968306293449
  90. HEYDEN G, 1970, Odontologisk Revy, V21, P129
  91. Huisingh-Scheetz M, 2017, J GERIATR ONCOL, V8, P8, DOI 10.1016/j.jgo.2016.06.003
  92. Jadczak Agathe D, 2016, JBI Database System Rev Implement Rep, V14, P93
  93. Jatoi A, 2017, ANN ONCOL, V28, P1957, DOI 10.1093/annonc/mdx232
  94. Johannsmeyer S, 2016, EXP GERONTOL, V83, P112, DOI 10.1016/j.exger.2016.08.005
  95. Johns N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083618
  96. Koppe L, 2019, J CACHEXIA SARCOPENI, V10, P479, DOI 10.1002/jcsm.12421
  97. Kreider RB, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0173-z
  98. LaCroix AZ, 2010, OSTEOPOROSIS INT, V21, P919, DOI 10.1007/s00198-009-1056-1
  99. Larsson L, 2019, PHYSIOL REV, V99, P427, DOI 10.1152/physrev.00061.2017
  100. Liu CK, 2011, CLIN GERIATR MED, V27, P101, DOI 10.1016/j.cger.2010.08.001
  101. Lobo DM, 2015, EXP GERONTOL, V70, P97, DOI 10.1016/j.exger.2015.07.012
  102. Lonbro S, 2013, ACTA ONCOL, V52, P310, DOI 10.3109/0284186X.2012.741325
  103. Louis M, 2003, MUSCLE NERVE, V27, P604, DOI 10.1002/mus.10355
  104. MACRAE PG, 1992, J ORTHOP SPORT PHYS, V16, P123, DOI 10.2519/jospt.1992.16.3.123
  105. Miranda H, 2011, SPECTROSC-BIOMED APP, V25, P225, DOI 10.1155/2011/212038
  106. Morley JE, 2012, J NUTR HEALTH AGING, V16, P601, DOI 10.1007/s12603-012-0084-2
  107. Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735
  108. Murai IH, 2015, OSTEOPOROSIS INT, V26, P1395, DOI 10.1007/s00198-014-3017-6
  109. Neves M, 2011, APPL PHYSIOL NUTR ME, V36, P419, DOI [10.1139/h11-014, 10.1139/H11-014]
  110. Nomura A, 2003, BRIT J PHARMACOL, V139, P715, DOI 10.1038/sj.bjp.0705316
  111. Norman K, 2006, CLIN NUTR, V25, P596, DOI 10.1016/j.clnu.2006.01.014
  112. Ofori-Asenso R, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8398

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/17